Flu Vaccines Market, trends, share, industry size, growth, opportunities, and forecast by 2029

Flu Vaccines Market research report considers the important parameters namely market analysis, market definition, market segmentation, key market trends, competitive analysis and research methodologies. For detailed market reports, you can request an analyst meeting or submit an inquiry at any time. This report provides an estimate of Compound Annual Growth Rate (CAGR) % for the forecast period and helps clients to make decisions based on future graphs. The Premium Flu Vaccines Market report provides the CAGR value changes during the forecast period 2023-2030 of the market.

Authoritative Flu Vaccines Market Report is a helpful resource providing current and upcoming technical and financial details of the industry to 2030. Industry reports are primarily distributed to users in PDF or spreadsheet format. However, PPT format can also be specified upon request. Moreover, statistical and numerical data such as facts and figures are very well presented in the report through charts, tables, or graphs. You can rest assured that the information in the trusted Flu Vaccines Market Report comes from only valuable and authentic resources.

Data Bridge Market Research analyses that the flu vaccines market which was USD 7.5 billion in 2021, would rocket up to USD 14.83 billion by 2029, and is expected to undergo a CAGR of 8.90% during the forecast period 2022 to 2029

Market Overview

Vaccinations against influenza are referred to as “flu injections” or “influenza vaccinations”. The influenza virus’s fast evolution, a new vaccination is created twice a year. Although this changes from year to year, the most offer modest to strong protection against influenza. There is little evidence among persons over 65. On average, they missed their work days by one and a half days. A child’s surroundings may be protected through vaccination.

Explore Further Details about This Research Flu Vaccines Market Report https://www.databridgemarketresearch.com/reports/global-flu-vaccines-market

Global Flu Vaccines Market Dynamics

Drivers

Surging volume of patients suffering from Flu

The characteristics of circulating viruses, the timing of the season, how well the vaccine protects against illness, and how many people received vaccinations all play a role in determining the severity of flu disease in the United States. Flu has a variety of consequences. CDC estimates that flu has resulted in 9 million – 41 million illnesses, 140,000 – 710,000 hospitalizations and 12,000 – 52,000 deaths annually between 2010 and 2020. This will boost market’s growth.

Raising awareness of immunization

One of the most effective and economical health interventions in the world, vaccination saves millions of lives every year. Worldwide, vaccinations prevent infectious diseases such as hepatitis, diphtheria, tetanus, pertussis (whooping cough), measles, and polio from killing up to 3 million people each year. Nevertheless, despite the vaccines’ demonstrable efficacy and the tens of millions of lives they have saved, an estimated 400 000 people in the Western Pacific Region pass away needlessly each year from diseases that immunizations could have prevented. Up to 800 000 kids are not immunised each year, and more than 3.2 million kids reside in areas with immunisation coverage rates under 80%. This will boost the market growth.

Opportunities

Government initiatives

According to a recent survey conducted in the 190 districts where Mission Indradhanush has recently been implemented, the percentage of children who have received all recommended vaccinations has grown by 18.5% since pre-Mission Indradhanush estimations. To achieve and maintain India’s goal of 90% full immunisation coverage, Mission Indradhanush’s lessons are being applied to find all uninvited children nationwide.

Some of the major players operating in the flu vaccine market are:

AstraZeneca (U.K.)
BioDiem (Canada)
Novasep (France)
MerckKGaA (Germany)
Charles River Laboratories (U.K.)
uniQure N.V. (Netherlands)
Waisman Biomanufacturing (U.S.)
Creative-Biogene (U.S.)
Aldevron (U.S.)
Oxford Biomedica (U.K.)
Thermo Fisher Scientific Inc (U.S.)
Fujifilm Corporation (Japan)
Spark Therapeutics Inc. (U.S.)
ABL Inc. (U.S.)
Boehringer Ingelheim International GmbH. (Germany)
Brammer Bio (U.S.)
Pfizer Inc. (U.S.)

Key Offerings:

Past Market Size and Competitive Landscape (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Market Size, Share, Size & Forecast by different segment | 2023−2029
Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Flu Vaccines Market Segmentation – A detailed analysis by segment with their sub-segments and Region
Competitive Landscape – Profiles of selected key players by region from a strategic perspective
Competitive landscape – Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER’s analysis
Value chain and supply chain analysis
Legal Aspects of Business by Region
Lucrative business opportunities with SWOT analysis
Recommendations